Fosinopril sodium, >=98% (HPLC), powder

Fosinopril sodium, >=98% (HPLC), powder

Biochem/physiol Actions

Fosinopril is an angiotensin converting enzyme (ACE) inhibitor. Fosinopril is also known to inhibit the activity of the peptide transporter PEPT2.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

General description

Fosinopril lowers blood pressure and functions as an antihypertensive agent. It is an ester prodrug. Fosinopril is metabolised by the liver and excreted from the body by liver and kidney. It is used to treat heart failure.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573371 Fosinopril sodium, >=98% (HPLC), powder white to off-white 100 TVTJZMHAIQQZTL-TXDYNIFHSA-M 1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,3 SIGMA-ALDRICH powder ≥98% (HPLC)
£578.04 (exc VAT) per 25MG
-
+
3573372 Fosinopril sodium, >=98% (HPLC), powder white to off-white 100 TVTJZMHAIQQZTL-TXDYNIFHSA-M 1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,3 SIGMA-ALDRICH powder ≥98% (HPLC)
£164.36 (exc VAT) per 5MG
-
+